MDMA for Co-occurring PTSD and OUD After Childbirth

PHASE2RecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

April 30, 2027

Study Completion Date

November 30, 2027

Conditions
Stress Disorders, Post-TraumaticOpioid Use Disorder
Interventions
DRUG

MDMA Assisted Therapy

"The intervention is MDMA Assisted Therapy focused on PTSD and three experiment sessions with the first session using an initial dose of 100 mg MDMA HCL (\~80 mg MDMA) with supplemental dose of 40 mg MDMA HCL (\~35 mg MDMA). Total dose range for the first session is 100 mg MDMA HCL (\~80 mg MDMA) to 140 mg MDMA HCL (\~115 mg MDMA).The second and third sessions may use an initial dose of 120 mg MDMA HCL (\~100 mg MDMA) with a supplemental dose of 60 mg MDMA HCL (\~50 mg MDMA) for a total dose range of 120 mg MDMA HCL (\~100 mg MDMA) to 180 mg MDMA HCL (\~160 mg MDMA)~Total cumulative dose range for the three sessions is 340mg MDMA HCL (\~280 mg MDMA) to 500 mg MDMA HCL (\~435 mg MDMA)"

Trial Locations (1)

87131

RECRUITING

University of New Mexico Health Sciences, Albuquerque

All Listed Sponsors
collaborator

Multidisciplinary Association for Psychedelic Studies

OTHER

lead

University of New Mexico

OTHER